Delivery Order SPE2DB20D9331-SPE2DB23FL0T8

Award Date 3/7/23
Potential Completion Date 3/28/23
Potential Value $32K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,458.40, is a firm fixed-price delivery order for the pharmaceutical product VABYSMO 6 MG/0.05 ML VIAL 0.05ML. The contract has an ultimate completion date of February 3, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,224.44 firm fixed-price delivery order is for the provision of VABYSMO 6 MG/0.05 ML VIAL 0.05ML pharmaceutical products. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This federal contract award, with the ID SPE2DB25D9305|SPE2DB25FQACJ, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, under a firm fixed-price delivery order contract with a ceiling value of $5,833.60 and a performance period through February 21, 2025. The contract is not associated with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,112.22, is a firm fixed-price delivery order for the pharmaceutical product VABYSMO 6 MG/0.05 ML SYRINGE 0.05ML. The contract has an ultimate completion date of January 27, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $49,795.52, is for the delivery of VABYSMO 6 mg/0.05 mL vial 0.05 mL to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,224.44 firm fixed-price delivery order is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a period of performance through May 20, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, which is a large Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. This delivery order, valued at $3,112.22, is for the pharmaceutical product VABYSMO 6 MG/0.05 ML VIAL 0.05ML. The contract is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,112.22 firm fixed-price delivery order is for the pharmaceutical product VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with an ultimate completion date of November 7, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,668.33 firm fixed-price delivery order is for the pharmaceutical product VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a delivery deadline of September 19, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a ceiling value of $6,224.44 for the provision of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. The contract is a firm fixed-price arrangement with a completion date of June 11, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB23FL0T8
    Delivery Order

This federal contract award, with an ID of SPE2DB20D9331|SPE2DB23FL0T8, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,009.00 firm fixed-price delivery order is for the supply of the drug VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with an ultimate completion date of March 28, 2023.

DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 1/9/25, 9:34 AM